Cited by 85Wound Healing and TreatmentsPhytochemistry and biological activity of medicinal plantsTissue Engineering and Regenerative Medicine

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing

Open access
Galeano, Mariarosaria, Pallio, Giovanni, Irrera, Natasha, Mannino, Federica, Bitto, Alessandra, Altavilla, Domenica, Vaccaro, Mario, Squadrito, Giovanni +4 more·2021·Pharmaceuticals

Abstract

The normal wound healing process is characterized by a complex, highly integrated cascade of events, requiring the interactions of many cell types, including inflammatory cells, fibroblasts, keratinocytes and endothelial cells, as well as the involvement of growth factors and enzymes. However, several diseases such as diabetes, thermal injury and ischemia could lead to an impaired wound healing process characterized by wound hypoxia, high levels of oxygen radicals, reduced angiogenesis, decreased collagen synthesis and organization. Polydeoxyribonucleotide (PDRN) has been used to improve wound healing through local and systemic administration thanks to its ability to promote cell migration and growth, angiogenesis, and to reduce inflammation on impaired wound healing models in vitro, in vivo and clinical studies. In light of all these observations, the aim of this review is to provide a full overview of PDRN applications on skin regeneration. We reviewed papers published in the last 25 years on PubMed, inserting “polydeoxyribonucleotide and wound healing” as the main search term. All data obtained proved the ability of PDRN in promoting physiological tissue repair through adenosine A2A receptor activation and salvage pathway suggesting that PDRN has proven encouraging results in terms of healing time, wound regeneration and absence of side effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ph14111103

Cites

57 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PDRN-based injectable pharmaceuticals are frequently used in dermatological practice because of multifactorial benefits, including tissue regeneration, dermal rejuvenation, hypopigmentation, wound healing, anti-inflammatory effects, anti-aging properties, and promotion of hair regrowth.

    “PDRN-based injectable pharmaceuticals are frequently used in dermatological practice because of their multifactorial benefits, including tissue regeneration, dermal rejuvenation, hypopigmentation, wound healing, anti-inflammatory effects, anti-aging properties, and promotion of hair regrowth [23,147].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [23]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • PDRN is composed of a linear structure of deoxyribonucleotides linked by phosphodiester bonds, which is double stranded.

    “PDRN, similar to PN, is composed of a linear structure of deoxyribonucleotides linked by phosphodiester bonds, which is double stranded [11,23].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [48]Squadrito F. Bitto A. Altavilla D. Arcoraci V. De Caridi G. De Feo M.E. Corrao S. Pallio G. Sterrantino C. Minutoli L. The effect of PDRN, An adenosine receptor A2A agonist, On the healing of chronic diabetic foot ulcers: Results of a clinical trial J. Clin. Endocrinol. Metab. 2014 99 E746 E753 24483158

Cited by

Sorted by citations

Authors
Galeano, M., Pallio, G., Irrera, N., Mannino, F., Bitto, A., Altavilla, D., Vaccaro, M., Squadrito, G., Arcoraci, V., Colonna, M. R., Lauro, R., & Squadrito, F.
Affiliations
University of Messina (IT)
Corresponding author
Squadrito, Francesco
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2021-10-29
Volume
14
Issue
11
Pages
1103
ISSN
1424-8247 (ISSN-L)
OpenAlex
W3208112815
Cited by
79
References
58
Citations by year
2026: 28 · 2025: 25 · 2024: 11 · 2023: 11 · 2022: 4
FWCI
0.75
Type
journal article
Language
en
Open access
Locations
  • Pharmaceuticals (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and biological activity of medicinal plants
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
polydeoxyribonucleotide, wound healing, delayed wound healing, skin regeneration, angiogenesis, inflammation, adenosine A2A receptor, salvage pathway, cell migration, collagen synthesis, diabetes mellitus, burns, ischemia, wound hypoxia, oxygen free radicals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review